Renovo Share Discussion Threads

[wh1spa] 02/2/2012 11:02

could be him

[alimo] 01/2/2012 19:39

Yeh, who's this Charles Davies and what does he know that we don't. He's gone for a fairly big slice, as many of us give up and go elsewhere.

I'm still puzzled about the Juvista mystery. Shire wanted it, and then didn't, maybe after they saw another form of skin regeneration method that on the surface might look to have bigger benefits. But even that method might not turn out to be as good as Juvista. Seems people can make what seems to be big big mistakes, and then just say sorry for spending £millions on research over decades, that convinces the committees of this and that esteemed scientific institution, and then when oops it doesn't work, off they go leaving us to wonder why they bothered to spend a career in researching their baby, which turns out to be a dud. (Or maybe, not such a big dud after all, judging by those who keep wanting to scoop up the shares.)

Let us also remember that while MANY shareholders have invested in Juvista because of all the good news that was consistantly reported, a FEW SHORTERS (notice I don't call them shareholders) will have made a real killing when the share price plunged sharply, on two occasions. What we need to know is who the few SHORTERS who profited were, and get their stories.

So, could Shire have said to RNVO, we'll let you keep the cash and Juvista, if you ensure Phase III fails and let's us off the hook of the further larger payments that are due? I mean come on, in Nov 2010 we get a RNS saying a separate Juvista Phase III trial for paedriatrics is showing excellent results from the 85 or so young patients.

The main trial reports in Feb 2011. And hey-presto it's suddenly a disaster, not meeting any of its end points. So the Phase III trial that cost £millions, that follows on from successful Phase II and I trials (which show pictures that indicate that Juvista works well), is a disaster. In previous and other product trials, we heard about how patients were monitored to observe their scars at interim periods of time eg 26 weeks etc. In the main Juvista PIII trial that cost £millions, was there no interim reporting or observing that would have shown that the end points were failing? There were reports about how they were being successful in finding enough patients for the trial, which had over 300 signed up in multi centres. Surely the results for many of the patients would come in at different times, because some would start their treatment quite a bit earlier than others. Was the Prof's team not privy to, or interested enough to make enquiries about how the Juvista Trial was working?

They released the successful Juvista(paediatric) report out of the blue in advance of the on schedule expected H1 PIII report. Good news, for those of us who had been waiting for years, which saw the shares rocket up again, only to be followed three months later with the disasterous news in Feb 2011 which seemed to indicate that Juvista was a load of rubbish.

What puzzles me is that Shire might still be holding 12million+ shares. Why, if there's nowt to hope for! Maybe there is much more to come out as the scramble for the intellectual property really starts. Or will the directors that remain (only a few now) have things so tied up and under THEIR control that they will secrete all the IP away for sweeties. Have we time to wait and see, or is there a white knight just waiting to blow the whistles. You've got to have real friends to pull off a plan. Hopefully, our friends are thinking of and minding the investments of all our SHAREHOLDERS, large and small.

It will be really interesting if the final Trial results in another DUD. Then I'd ask ......why? But then I'd also ask why, if it is a success, when Juvista(P) is a success, and Juvista isn't.

[wh1spa] 01/2/2012 12:02

someone's confident

[grahamg8] 11/1/2012 16:53

bachellor. They certainly could. Once the buy back is completed at a cost of around £8m there will still be around £27m cash left. But my impression is that they are hoping to find a buyer of the business as a cash shell. I'm sure the larger shareholders will ensure any decision maximises shareholder value so just about anything is possible. The one thing certain to me is that the shares are still worth more than 17pps.

[bachellor] 11/1/2012 15:04

are we getting some sort of special dividend?

[hollerich1] 09/1/2012 17:26

ferguson has not bailed out, infact this may be a good opportunity to redevelop the scar treatment medicine and this time with government money.

[texas tea] 09/1/2012 16:00

Renovo Group: Brooke to succeed Ferguson as chairman
3:50 pm by Giles Gwinnett

[texas tea] 09/1/2012 16:00

Renovo Group: Brooke to succeed Ferguson as chairman
3:50 pm by Giles Gwinnett

[g_s] 09/1/2012 14:12

Hey carnivale,

Nope, actually finally decided to sell off just after Xmas. Just didn't have the patience anymore, or indeed spare cash unfortunately. I see Ferguson has now bailed. I don't personally see much upside from here. It's a safe, but fairly dull investment IMO. Cheers.

GS

[carnivale] 29/12/2011 12:44

Gsound are you still about ?

[argylerich] 23/12/2011 12:27

Big buys by the company, but certainly look more pre-arranged than off the trading floor...

[bachellor] 14/12/2011 16:24

any ideas on cash now. hold from20p. tia

[sbs] 09/12/2011 20:31

Was lucky enough to get out at a profit the first time. Bought back in after the big drop, and sold out again after a few months today for 0.5p/share. Beats bank interest, anyway!

PS Notice several big buys going through today.

[alimo] 30/11/2011 12:14

Another waiting for the real value to come. Wish they would share what the Board know - something called fiduciary duty owed to all holders, big and small. Maybe this sort of duty is outdated, a right that is now wrong!

I wonder who wants Juvista now that we and Shire don't seem to - seeing what it did for those patients during Phase II, I'd be one asking for treatment if I had the kind of scars it healed, specially if I was a youngster. It's about this time last year that the Prof announced that Juvista( met all (or most) of its targets/end points, and the shares shot up to 60+.

Let's nostalgically read that report again :-

Juvista Trial Results
Share this article PrintAlert
TIDMRNVO

RNS Number : 6146W

[bobbarker] 25/11/2011 18:47

Could it be this guy?

[wh1spa] 25/11/2011 18:31

sorry to be so ignorant but who is Charles Davies?

[alimo] 23/11/2011 16:21

Surely a fortune! People who know are scooping up the shares as they come on the market. All the speculators have gone long ago, but the big money must be staying around for the real value to come.

[hollerich1] 18/11/2011 18:52

so what is this worth now.

[praipus] 18/11/2011 14:41

Anyone interested in where Weiss might have put the money from selling their RNVO holding see post 3 on the WAM thread, link below.

[sir rational] 18/11/2011 11:53

Looks about right to me given the uncertainty about what BOD will do with the remaining cash (acquisitions in this kind of scenario are invariably screwed up) plus the fact that the remaining players would walk away with generous redundancy packages if everything is wound up next year.

[praipus] 18/11/2011 11:39

Weiss Asset Management clearly dont think there will be a special dividend.



However the share price hasnt moved implying someone else has mopped up the shares and hasnt disclosed yet so perhaps the MM's want some more shares to fill the order.

18p in cash +IP +staff and knowledge surely the share price should be a little bit higher.

[bachellor] 18/11/2011 09:25

are we going to get a special dividend?

[hollerich1] 12/11/2011 18:06

all of these have been sells and the share price has'nt nose dive, what is fishy.

[wh1spa] 09/11/2011 10:13

Hang fire! Was that a trade of £23.72 that just went through. Blimey something must be cooking!

[waterloo01] 01/11/2011 09:27

Barclays offered to transfer to non isa account for free. sold some (as would rather the money stayed in the ISA) and transfered some. Price held up really well so is a decent buyer mopping these up.